Semaglutide is laboratory profile and efficacious for NASH resolution [PMID: 33257834] Laboratory literature summary: Semaglutide is laboratory profile and efficacious for NASH resolution
Probiotics: Emerging but Not Yet Definitive Specific probiotic strains may reduce GI symptoms in the context of metabolic interventions, though direct evidence for GLP-1-agonist-associated nausea is limited
Contributing health factors: Discuss comorbid health conditions such as diabetes, hypertension (high blood pressure), cardiovascular disease, high cholesterol levels, and liver and kidney diseases with your doctor so they can make a personalized treatment plan for you
Today, GLP-1 medications are FDA-approved not only for diabetes, but also for weight management in adults who meet certain criteria
Para que serve
They acknowledged that while the link between GLP-1 drug use and fertility improvement is encouraging, the studys sample size was relatively small, and longer-term effects remain unknown